KMDA
KamadaNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$452.70M
P/E Ratio
22.37
EPS
$0.35
Beta
0.20
52W High
$9.07
52W Low
$6.31
50-Day MA
$8.27
200-Day MA
$7.64
Dividend Yield
3.19%
Profit Margin
11.20%
Forward P/E
18.45
PEG Ratio
0.74
About Kamada
Kamada Ltd. develops, produces and markets plasma-derived protein therapies for orphan indications. The company is headquartered in Rehovot, Israel.
Fundamentals
| Revenue (TTM) | $181.68M |
| Gross Profit (TTM) | $74.77M |
| EBITDA | $38.91M |
| Operating Margin | 15.40% |
| Return on Equity | 7.97% |
| Return on Assets | 4.19% |
| Revenue/Share (TTM) | $3.12 |
| Book Value | $4.39 |
| Price-to-Book | 1.74 |
| Price-to-Sales (TTM) | 2.49 |
| EV/Revenue | 2.165 |
| EV/EBITDA | 10.28 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 2.80% |
| Shares Outstanding | $57.69M |
| Float | $11.07M |
| % Insiders | 7.20% |
| % Institutions | 48.63% |
Historical Volatility
HV 10-Day
49.34%
HV 20-Day
38.22%
HV 30-Day
35.41%
HV 60-Day
33.23%
HV Rank
58.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($13.00 target)
3
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026